Diamond Member: Welch Allyn

At Welch Allyn, we are pragmatic visionaries focused on helping healthcare providers overcome complex challenges with simple solutions. We approach each day with a simple commitment—deliver the everyday practical diagnostic tools that help doctors and nurses provide better care for their patients. Since 1915, we have continually applied practical innovations in ways that help healthcare professionals deliver more advanced and comprehensive care, optimize their time and skill, and improve their patients’ outcomes.

Silver Member: Abbott

Every day and around the world, Abbott is discovering new ways to make life better – creating more possibilities for more people through the power of health.

Silver Member: Revelar

Revelar is a leading breath diagnostics company focused on analyzing key biomarkers in point-of-care settings to provide critical data points and accelerate efficacy in disease prevention, detection, and personalized treatment protocols.

We are revolutionizing healthcare by revealing personal health metrics with the power to shape the future of human health and longevity.

Apical

Apical LLC is an Ag-tech Company that combines modern analytical methods, eco-friendly growing products and smart data management techniques to provide growers with the tools they need to grow extremely healthy, optimal yielding crops organically with minimal pest problems.

Astoria-Pacific

Established in Oregon in 1990, Astoria-Pacific, Inc. manufactures quality reagent kits and high-throughput analytical instrumentation for clinical, environmental, and wine testing laboratories worldwide. We are proud to partner with newborn screening programs, manufacturing our FDA-cleared SPOTCHECK® brand of in vitro diagnostics under an ISO 13485 certified quality management system. Research is a core enterprise and we’re keen on exploring biotechnology collaborations to improve product usability and integrate new assay tools. Additionally, our cGMP manufacturing experience positions Astoria-Pacific as a potential […]

Bates Medical Systems

Bates Medical Systems LLC (BMS) is developing innovative and cost effective new technology for the detection and diagnosis of breast cancer, one of the leading causes of death among women. BMS’s Automated Breast Ultrasound System (ABUS) provides a pre-operative, non-ionizing radiation evaluation of the breast to accurately identify tumor size and location without compression.

Biomed

Biomed Diagnostics Inc.

Biomed Diagnostics Inc. is an innovative manufacturer of microbiology diagnostic devices that save money and time, improve workflow and throughput, and reduce sample exposure and contamination.

By combining sample collection, transport and culture in a single platform, the Biomed point-of-care InPouchtm and InTraytmdevices help medical professionals, veterinarians, research teams, environmental and industry scientists worldwide accurately detect, identify, enumerate and differentiate pathogens and non-pathogens.

CardioWise, Inc.

CardioWise, Inc. has developed an advanced Machine Learning (ML) Platform for cardiac imaging. We provide unprecedented new diagnostic insights to physicians by utilizing commonly available clinical images and delivering quantitative, meaningful results via the existing physician workflow. CardioWise ML analyses increase objectivity in decision-making; and improve day-to-day clinical cardiac practice, saving lives, while reducing the cost of care worldwide.

Heart Disease is the leading cause of death. The key to survival is early detection, effective intervention and post treatment monitoring. Since […]

DiabetOmics, Inc.

DiabetOmics, Inc. is a global medical diagnostics company pioneering innovative, non-invasive point-of-care tests for the detection and monitoring of diabetes.

Our mission is to advance the health and wellbeing of people with, or at risk for, diabetes through simple, cost-effective, and easily accessible care.

We strive to develop and provide point-of-care testing capabilities that are especially useful in alleviating the substantial economic and public health burden of diabetes in underserved, low-resource environments, particularly for at-risk populations in low/middle-income countries.